These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4782259)

  • 1. [Biopharmaceutics. II. Methods of determination and criteria for expression of dissolution velocity].
    Cadorniga R; Arias I
    Boll Chim Farm; 1973 Oct; 112(10):635-44. PubMed ID: 4782259
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biopharmacy. Note IV. Influence of the technologic process and bile salts on the biopharmaceutic parameters in vitro of flufenamic acid in tablets].
    Arias I; Cadorniga R
    Boll Chim Farm; 1974 Feb; 113(2):82-90. PubMed ID: 4848139
    [No Abstract]   [Full Text] [Related]  

  • 3. Some dissolution aspects of ferrous sulfate tablets.
    Blezek CE; Lach JL; Guillory JK
    Am J Hosp Pharm; 1970 Jul; 27(7):533-9. PubMed ID: 5431051
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
    Kortejärvi H; Urtti A; Yliperttula M
    Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biopharmacy. 3. Influence of solvents and agglutinins on the biopharmaceutic parameters in vitro of flufenamic acid in tablets].
    Arias I; Cadorniga R
    Boll Chim Farm; 1973 Dec; 112(12):804-12. PubMed ID: 4793201
    [No Abstract]   [Full Text] [Related]  

  • 6. The bioavailability of flufenamic acid and its dissolution rate from capsules.
    Kaniwa N; Ogata H; Aoyagi N; Shibazaki T; Ejima A; Watanabe Y; Motohashi K; Sasahara K; Nakajima E; Morioka T; Nitanai T
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):56-63. PubMed ID: 6840926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Equivalency of drugs and the problem of biological availability].
    Hirtz J
    Rev Prat; 1973 Nov; 23(53):7-10. PubMed ID: 4802222
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid in vivo dissolution of ketoprofen: implications on the biopharmaceutics classification system.
    Granero GE; Ramachandran C; Amidon GL
    Pharmazie; 2006 Aug; 61(8):673-6. PubMed ID: 16964708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Bio-availability and clinical efficacy of a drug.
    Ganguli LK
    J Indian Med Assoc; 1973 Jul; 61(2):94-5. PubMed ID: 4759083
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biopharmaceutics and drug formulation].
    Riccieri FM
    Ann Ist Super Sanita; 1982; 18(3):541-6. PubMed ID: 7187842
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioavailability of codeine preparations in the rat.
    Strolin Benedetti M; Larue DA
    Arzneimittelforschung; 1973 Jun; 23(6):826-8. PubMed ID: 4740769
    [No Abstract]   [Full Text] [Related]  

  • 12. Biopharmaceutics classification systems for new molecular entities (BCS-NMEs) and marketed drugs (BCS-MD): theoretical basis and practical examples.
    Papadopoulou V; Valsami G; Dokoumetzidis A; Macheras P
    Int J Pharm; 2008 Sep; 361(1-2):70-7. PubMed ID: 18614303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubilization and dissolution of insoluble weak acid, ketoprofen: effects of pH combined with surfactant.
    Sheng JJ; Kasim NA; Chandrasekharan R; Amidon GL
    Eur J Pharm Sci; 2006 Nov; 29(3-4):306-14. PubMed ID: 16982177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro drug release rate as a standard requirement.
    Láng B
    Pharmazie; 1971 Nov; 26(11):661-4. PubMed ID: 5154319
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on flufenamic acid capsules and tablets.
    Akbuğa J; Gülhan S; Bayraktar-Alpmen G
    Pharmazie; 1983 Jul; 38(7):478-80. PubMed ID: 6634915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system.
    Dokoumetzidis A; Macheras P
    Int J Pharm; 2006 Sep; 321(1-2):1-11. PubMed ID: 16920290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical application of the concept of mean times in biopharmaceutics.
    Voegele D
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):597-604. PubMed ID: 6513676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectivness prolongation of drugs with special consideration for peroral depot drug forms].
    Hänselmann B; Voigt R
    Pharmazie; 1971 Feb; 26(2):57-77. PubMed ID: 4930108
    [No Abstract]   [Full Text] [Related]  

  • 19. Biopharmaceutical characterization of sotalol-containing oral immediate release drug products.
    Alt A; Potthast H; Moessinger J; Sickmüller B; Oeser H
    Eur J Pharm Biopharm; 2004 Jul; 58(1):145-50. PubMed ID: 15207548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative biopharmaceutical study of tegalide].
    Lopatina NB; Lebedeva MN
    Med Parazitol (Mosk); 2000; (1):27-9. PubMed ID: 10808715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.